Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity
CONCLUSION These findings indicate that human BAT metabolic activity can be increased after chronic pharmacological stimulation with mirabegron and support the investigation of β3-AR agonists as a treatment for metabolic disease.TRIAL REGISTRATION Clinicaltrials.gov NCT03049462.FUNDING This work was supported by grants from the Intramural Research Program of the NIDDK, NIH (DK075112, DK075116, DK071013, and DK071014).
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Alana E. O’Mara, James W. Johnson, Joyce D. Linderman, Robert J. Brychta, Suzanne McGehee, Laura A. Fletcher, Yael A. Fink, Devika Kapuria, Thomas M. Cassimatis, Nathan Kelsey, Cheryl Cero, Zahraa Abdul Sater, Francesca Piccinini, Alison S. Baskin, Broo Source Type: research
More News: Bile | Biomedical Science | Cholesterol | Eating Disorders & Weight Management | Grants | Hormones | Insulin | Obesity | Overactive Bladder | Overactive Bladder Syndrome | Pharmaceuticals | Study | Women